Thioguanine versus mercaptopurine in childhood ALL.
Stanulla
Martin
M
Department of Paediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany. Stanulla.Martin@MH-Hannover.de
Schünemann
Holger J
HJ
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D018572:Disease-Free Survival; D006801:Humans; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013866:Thioguanine / Q000009:adverse effects / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine; D013866:Thioguanine